Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 9/15/22 → 7/10/25 |
Funding
- Medpace Inc: $42,027.00
22-MULTI-49-OM-PMC: OM-GRPR1-02, A Phase 1 Open-Label Dose Escalation and Expansion Study to Determine the Safety, Tolerability, Dosimetry, and Preliminary Efficacy of ???Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Yang, Eddy (PI)
- Kunos, Charles (Former PI)